Efficacy of Early Combination Therapy With Lianhuaqingwen and Arbidol in Moderate and Severe COVID-19 Patients: A Retrospective Cohort Study

Efficacy of Early Combination Therapy With Lianhuaqingwen and Arbidol in Moderate and Severe COVID-19 Patients: A Retrospective Cohort Study

ObjectiveSince the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Wuhan City, China, coronavirus disease 2019 (COVID-19) has become a global pandemic. However, no special therapeutic drugs have been identified for COVID-19. The aim of this study was to search for drugs t...

Full description

Bibliographic Details
Main Authors: Jie Fang, Hui Li, Wei Du, Ping Yu, Ying-Yun Guan, Shi-Yu Ma, Dong Liu, Wei Chen, Guo-Chao Shi, Xiao-Lan Bian
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-09-01
Series:Frontiers in Pharmacology
Subjects:
COVID-19
SARS-CoV-2
Arbidol
Lianhuaqingwen
combination therapy
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2020.560209/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2020.560209/full

Similar Items